ICON plc (ICLR)

NASDAQ: ICLR · IEX Real-Time Price · USD
220.63
+3.14 (1.44%)
At close: Jun 24, 2022 4:00 PM
220.80
+0.17 (0.08%)
After-hours: Jun 24, 2022 5:27 PM EDT
1.44%
Market Cap 17.98B
Revenue (ttm) 6.52B
Net Income (ttm) 168.03M
Shares Out 81.50M
EPS (ttm) 2.24
PE Ratio 98.72
Forward PE 17.30
Dividend n/a
Ex-Dividend Date n/a
Volume 480,797
Open 221.46
Previous Close 217.49
Day's Range 218.49 - 223.26
52-Week Range 196.34 - 313.00
Beta 0.97
Analysts Buy
Price Target 277.36 (+25.7%)
Earnings Date Jul 27, 2022

About ICLR

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase resea... [Read more...]

Industry Life Sciences Tools & Services
IPO Date May 15, 1998
CEO Stephen Cutler
Employees 39,300
Stock Exchange NASDAQ
Ticker Symbol ICLR
Full Company Profile

Financial Performance

In 2021, ICON plc's revenue was $5.48 billion, an increase of 95.93% compared to the previous year's $2.80 billion. Earnings were $153.19 million, a decrease of -53.91%.

Financial Statements

Analyst Forecast

According to 22 analysts, the average rating for ICLR stock is "Buy." The 12-month stock price forecast is 277.36, which is an increase of 25.71% from the latest price.

Price Target
$277.36
(25.71% upside)
Analyst Consensus: Buy
Stock Forecasts

News

ICON plc Schedules Second Quarter 2022 Earnings Conference Call

DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Second Quarter 2022 Earnings Conference Call

ICON plc to present at the H.C. Wainwright Global Investment Conference and the Jefferies Healthcare Conference

DUBLIN--(BUSINESS WIRE)--ICON plc to present at the H.C. Wainwright Global Investment Conference and the Jefferies Healthcare Conference

ICON Named Business & Finance Company of the Year and One of Forbes' Best Employers for Diversity

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device, and government organis...

ICON plc to present at the BofA Securities 2022 Healthcare Conference

DUBLIN--(BUSINESS WIRE)--ICON plc to present at the BofA Securities 2022 Healthcare Conference

Icon PLC (ICLR) Q1 Earnings and Revenues Beat Estimates

Icon PLC (ICLR) delivered earnings and revenue surprises of 1.85% and 1.14%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ICON Reports First Quarter 2022 Results

DUBLIN--(BUSINESS WIRE)--ICON Reports First Quarter 2022 Results

Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ICON plc to Webcast Analyst Day Meeting

DUBLIN--(BUSINESS WIRE)--ICON plc to Webcast Analyst Day Meeting

Icon PLC (ICLR) Q4 Earnings Meet Estimates

Icon PLC (ICLR) delivered earnings and revenue surprises of 0% and 0.81%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

ICON Reports Fourth Quarter and Full Year 2021 Results

DUBLIN--(BUSINESS WIRE)--ICON Reports Fourth Quarter and Full Year 2021 Results

ICON plc to Present at the 2022 Citi Healthcare Conference

DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the 2022 Citi Healthcare Conference

Why Icon PLC (ICLR) is Poised to Beat Earnings Estimates Again

Icon PLC (ICLR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ICON Issues Financial Guidance for Full Year 2022

DUBLIN--(BUSINESS WIRE)--ICON Issues Financial Guidance for Full Year 2022

ICON plc to Present at the 40th Annual JP Morgan Healthcare Conference

DUBLIN, Ireland--(BUSINESS WIRE)--ICON plc to Present at the 40th Annual JP Morgan Healthcare Conference

Stocks Extend Rebound; Tesla, Fortinet, Icon Make Strong Gains

Stocks Extend Rebound; Tesla, Fortinet, Icon Make Strong Gains Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market r...

Other symbols: FTNTTSLA

ICON Named Best Contract Research Organisation in Latest String of Industry Awards

DUBLIN--(BUSINESS WIRE)--ICON was named “Best CRO” at the Scrip Awards by Pharma Intelligence and to the World's Best Employer list by Forbes, among many awards won in 2021.

ICON Releases Environmental, Social and Governance Report

DUBLIN--(BUSINESS WIRE)--ICON Releases Environmental, Social and Governance Report

ICON Announces the Expansion of its Accellacare Site Network

DUBLIN, Ireland--(BUSINESS WIRE)-- #ICON--ICON announces the expansion of the Accellacare Site Network, with six new clinical research sites in Germany, Poland, Spain and the U.S.

ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th Annual Evercore ISI HealthCONx...

DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th Annual Evercore ISI HealthCONx Conference

Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates

Icon PLC (ICLR) delivered earnings and revenue surprises of 4.94% and 1.32%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

ICON Reports Third Quarter 2021 Results

DUBLIN--(BUSINESS WIRE)--ICON Reports Third Quarter 2021 Results

Icon PLC (ICLR) to Report Q3 Results: Wall Street Expects Earnings Growth

Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tánaiste announces multi-million Euro R&D support of ICON to accelerate decentralised clinical trial technology

DUBLIN, Ireland--(BUSINESS WIRE)-- #CRO--Dublin-based ICON plc has been awarded €4 million in R&D support to further enhance its data solutions and decentralised clinical trial technology.

ICON plc to Present at the Wells Fargo 16th Annual Healthcare Conference and the Baird Global Healthcare Conference

DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the Wells Fargo 16th Annual Healthcare Conference and the Baird Global Healthcare Conference

Icon PLC (ICLR) is an Incredible Growth Stock: 3 Reasons Why

Icon PLC (ICLR) possesses solid growth attributes, which could help it handily outperform the market.